Orient Biotech: The chairman proposed to repurchase shares not exceeding 50 million yuan

Orient Biotech announced that the company's chairman, Fang Jianqiu, proposed on June 17, 2025, to repurchase a portion of the company's shares through centralized bidding trading to maintain the company's value and shareholder rights. The total amount of repurchase funds will not exceed RMB 50 million, and the repurchase price ceiling will not be higher than 120% of the average trading price of the company's shares over the 30 trading days prior to the board's approval of the repurchase plan. The funds will come from the company's own or self-raised funds, and the repurchase period will not exceed 3 months. Mr. Fang Jianqiu has not bought or sold the company's shares in the six months prior to the proposal and has no plans to increase or decrease holdings during the repurchase period. The company will convene a board meeting as soon as possible to review the repurchase matter and will vote in favor of the repurchase proposal at the board meeting